Current reports
6-K
Moolec Has Received USDA Approval For The First Genetically Modified Pea In History
16 Oct 24
6-K
Moolec Science Presents Fiscal Year 2024 Annual Business Update
4 Oct 24
6-K
Moolec Received Nasdaq Bid Price Letter
13 Sep 24
6-K
Moolec and Bunge Sign Research & Collaboration Agreement
9 Aug 24
6-K
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
15 Jul 24
6-K
Report of Foreign Private Issuer
28 Jun 24
6-K
Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update
31 May 24
6-K
Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call
24 May 24
6-K
Moolec Announces New Patent Granting in the United States For Molecular Farming Platform
30 Apr 24
6-K
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins
23 Apr 24
Registration and prospectus
S-8
Registration of securities for employees
20 Sep 24
424B3
Prospectus supplement
2 Jul 24
424B3
Prospectus supplement
2 Jul 24
424B3
Prospectus supplement
29 Apr 24
424B3
Prospectus supplement
29 Apr 24
424B3
Prospectus supplement
15 Feb 24
424B3
Prospectus supplement
15 Feb 24
424B3
Prospectus supplement
16 Jan 24
424B3
Prospectus supplement
16 Jan 24
POS AM
Prospectus update (post-effective amendment)
15 Nov 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
17 Nov 23
EFFECT
Notice of effectiveness
17 Nov 23
EFFECT
Notice of effectiveness
10 May 23
EFFECT
Notice of effectiveness
9 May 23
CORRESP
Correspondence with SEC
5 May 23
CORRESP
Correspondence with SEC
4 May 23
CORRESP
Correspondence with SEC
4 May 23
EFFECT
Notice of effectiveness
4 Apr 23
EFFECT
Notice of effectiveness
28 Mar 23
CORRESP
Correspondence with SEC
23 Mar 23